BRF
RIGL icon

B. Riley Financial’s Rigel Pharmaceuticals RIGL Stock Holding History

B. Riley Financial’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-47,334
Closed -$1.52M – 178
2018
Q3 		$1.52M Buy
47,334
+14,834
+46% +$445K 0.43% 47
2018
Q2 		$920K Buy
+32,500
New +$1.16M 0.24% 78
2018
Q1 		– Sell
-17,650
Closed -$685K – 326
2017
Q4 		$685K Sell
17,650
-3,050
-15% -$116K 0.18% 132
2017
Q3 		$526K Buy
20,700
+400
+2% +$9.73K 0.14% 154
2017
Q2 		$554K Buy
+20,300
New +$556K 0.15% 142

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

B. Riley Financial's RIGL Position: Q4 2018 in Review

B. Riley Financial sold out of Rigel Pharmaceuticals (RIGL) in Q4 2018, closing a stake of 47,334 shares — an estimated $1.52M sold.

B. Riley Financial first reported a position in RIGL in Q2 2017 and held it in 5 quarters. The position peaked at $1.52M in Q3 2018. 133 funds tracked by Wall St. Rank hold RIGL as of Q4 2018.

  • B. Riley Financial reported no remaining Rigel Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • B. Riley Financial sold 47,334 Rigel Pharmaceuticals shares in Q4 2018, an estimated $1.52M.
  • B. Riley Financial first reported a position in Rigel Pharmaceuticals in Q2 2017 and held it in 5 quarters.
  • B. Riley Financial's Rigel Pharmaceuticals position peaked at $1.52M in Q3 2018.
  • 133 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2018.

Based on B. Riley Financial's 13F filing for Q4 2018, filed 7 Feb 2019.